Full Company Report
E.I. DuPont de Nemours is involved in science and technology in a range of disciplines including high-performance materials, specialty chemicals, pharmaceuticals and biotechnology. The company operates globally through strategic business units. Within the strategic business units, businesses manufacture and sell a wide range of products to many different markets, including the transportation, textile, construction, automotive, agricultural and hybrid seeds, nutrition and health, pharmaceuticals, packaging and electronics markets.
General Information
DU PONT (EI) DE
1007 MARKET ST
WILMINGTON, DE 19898
Phone: 3027741000
Fax: 302-774-7321
Web: http://www.dupont.com
Email: NA
| Industry | CHEM-DIVERSIFD |
| Sector | Basic Materials |
| Fiscal Year End | December |
| Last Reported Quarter | 03/31/2013 |
| Next EPS Date | 07/23/2013 |
Price and Volume Information
| Zacks Rank | ![]() |
| Yesterday's Close | 55.57 |
| 52 Week High | 56.78 |
| 52 Week Low | 41.67 |
| Beta | 1.52 |
| 20 Day Moving Average | 7,591,955.00 |
| Target Price Consensus | 53.04 |
% Price Change
| 4 Week | 5.35 |
| 12 Week | 16.97 |
| YTD | 25.35 |
Share Information
| Shares Outstanding (millions) | 919.07 |
| Market Capitalization (millions) | 51,072.83 |
| Short Ratio | 5.52 |
| Last Split Date | 06/13/97 |
% Price Change Relative to S&P 500
| 4 Week | 0.47 |
| 12 Week | 7.12 |
| YTD | 6.28 |
Dividend Information
| Dividend Yield | 3.24% |
| Annual Dividend | $1.80 |
| Payout Ratio | 0.48 |
| Change in Payout Ratio | -0.10 |
| Last Dividend Payout / Amount | 05/13/2013 / $0.45 |
EPS Information
| Current Quarter EPS Consensus Estimate | 1.36 |
| Current Year EPS Consensus Estimate | 3.89 |
| Estimated Long-Term EPS Growth Rate | 8.40 |
| Next EPS Report Date | 07/23/2013 |
Consensus Recommendations
| Current (1=Strong Buy, 5=Strong Sell) | 2.39 |
| 30 Days Ago | 2.39 |
| 60 Days Ago | 2.39 |
| 90 Days Ago | 2.39 |
Fundamental Ratios
P/E
| Current FY Estimate | 14.28 |
| Trailing 12 Months | 15.48 |
| PEG Ratio | 1.71 |
Price Ratios
| Price/Book | 4.23 |
| Price/Cash Flow | 10.66 |
| Price / Sales | 1.39 |
Current Ratio
| 03-31-13 | 1.95 |
| 12-31-12 | 1.56 |
| 09-30-12 | 1.58 |
Net Margin
| 03-31-13 | 12.67 |
| 12-31-12 | 7.45 |
| 09-30-12 | 7.89 |
Inventory Turnover
| 03-31-13 | 3.82 |
| 12-31-12 | 3.82 |
| 09-30-12 | 3.74 |
EPS Growth
| vs. Previous Year | -3.11% |
| vs. Previous Quarter | 1,318.18% |
ROE
| 03-31-13 | 31.50 |
| 12-31-12 | 33.55 |
| 09-30-12 | 36.65 |
Quick Ratio
| 03-31-13 | 1.34 |
| 12-31-12 | 1.02 |
| 09-30-12 | 1.10 |
Pre-Tax Margin
| 03-31-13 | 8.42 |
| 12-31-12 | 8.82 |
| 09-30-12 | 8.55 |
Debt-to-Equity
| 03-31-13 | 0.93 |
| 12-31-12 | 1.05 |
| 09-30-12 | 1.00 |
Sales Growth
| vs. Previous Year | -6.72% |
| vs. Previous Quarter | 38.67% |
ROA
| 03-31-13 | 6.73 |
| 12-31-12 | 6.86 |
| 09-30-12 | 7.34 |
Operating Margin
| 03-31-13 | 9.21 |
| 12-31-12 | 9.19 |
| 09-30-12 | 9.46 |
Book Value
| 03-31-13 | 13.14 |
| 12-31-12 | 10.66 |
| 09-30-12 | 11.26 |
Debt to Capital
| 03-31-13 | 47.81 |
| 12-31-12 | 50.69 |
| 09-30-12 | 49.51 |

